soul study semaglutide Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo SOUL Trial: Oral Semaglutide Reduces

GLP-1 receptor agonists are synthetic molecules that mimic the action of endogenous GLP-1 with significantly extended half-lives, enabling sustained metabolic effects

Many patients start with CJC/Ipa alone and add a second peptide at month 3-4 if goals warrant it

Exploring Weight Loss Solutions at St

Most semaglutide patients find that one 25-gram protein shake plus protein-rich meals (eggs, fish, Greek yogurt) keeps them satisfied and preserves muscle

GLP-1 medications work by: Reducing hunger signals Slowing gastric emptying Improving insulin sensitivity However, they dont permanently change the underlying biology that drives weight gain